Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash from Investing Activities (2022 - 2023)

Historic Cash from Investing Activities for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to $15.2 million.

  • Therapeutics' Cash from Investing Activities rose 1219.31% to $15.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$29.6 million, marking a year-over-year increase of 8775.3%. This contributed to the annual value of -$154.5 million for FY2024, which is 42151.85% down from last year.
  • According to the latest figures from Q4 2023, Therapeutics' Cash from Investing Activities is $15.2 million, which was up 1219.31% from -$17.9 million recorded in Q3 2023.
  • Therapeutics' 5-year Cash from Investing Activities high stood at $15.2 million for Q4 2023, and its period low was -$170.7 million during Q1 2022.